Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: Longitudinal results from the Massachusetts Women's Health Study

Journal of Clinical Epidemiology

Volumn 52, Issue 2, 1999, Pages 95-103

  Johannes, Catherine B ^a   Stellato, Rebecca K ^a   Feldman, Henry A ^a   Longcope, Christopher ^b   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Aging; Cardiovascular diseases; Dehydroepiandrosterone; Ischemic heart disease; Risk factors

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; ESTRADIOL; ESTRONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE; PRASTERONE SULFATE;

ADULT; AGING; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIOVASCULAR DISEASES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; LINEAR MODELS; LIPIDS; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MIDDLE AGED; RISK; RISK FACTORS;

EID: 0033022161     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00144-9     Document Type: Article

References (48)

1. Kask E. 17-ketosteroids and arteriosclerosis. Angiology. 10:1959;358-368.
2. Nafziger A.N., Herrington D.M., Bush T.L. Dehydroepiandrosterone and dehydroepiandrosterone sulfate. Their relation to cardiovascular disease Epidemiol Rev. 13:1991;267-293.
3. Orentreich N., Brind J.L., Rizer R.L. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:1984;551-555.
4. Orentriech N., Brind J.L., Vogelmen J.H., Andres R., Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab. 75:1992;1002-1004.
5. Gordon G.B., Bush D.E., Weisman H.F. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury J Clin Invest. 82:1988;712-720.
6. Herrington D.M., Gordon G.B., Achuff S.C., Trejo J.F., Weisman H.F., Kwiterovich P.O., Pearson T.A. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol. 16:1990;862-870.
7. Mitchell L.E., Sprecher D.L., Boreki J.B., Rice T., Laskarezewski P.M., Rao D.C. Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation. 89:1994;89-93.
8. Slowinska-Srzednicka J., Zgliczynski S., Ciswicka-Sznajderman M.et al. Decreased plasma dehydroepiandrosterone concentrations in young men after myocardial infarction. Atherosclerosis. 79:1989;197-203.
9. Slowinska-Srzednicka J., Makczewska B., Srzednicki M.et al. Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med. 237:1995;465-472.
10. Barrett-Connor E., Khaw K.-T., Yen S.S.C. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 315:1986;1519-1524.
11. LaCroix A.Z., Yano K., Reed D.M. Dehydroepiandrosterone sulfate, incidence of myocardial infarction and extent of atherosclerosis in men. Circulation. 86:1992;1529-1535.
12. Schaefer C., Friedman G., Ettinger B., Quesenberry C., Liu J., Haan M., Orentreich N., Vogelman J. Dehydroepiandrosterone sulfate (DHEAS), angina, and fatal ischemic heart disease. (Abstract). Am J Epidemiol. 143:1996;S69.
13. Newcomer L.M., Manson J.E., Barbieri R.L., Hennekens C.H., Stampfer M.J. Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians. A prospective study Am J Epidemiol. 140:1994;870-875.
14. Stampfer M.J., Colditz G.A. Estrogen replacement and coronary heart disease. A quantitative assessment of the epidemiologic evidence Preven Med. 20:1991;47-63.
15. Barrett-Connor E., Khaw K.-T. The epidemiology of DHEAS with particular reference to cardiovascular disease. The Rancho Bernardo Study Kalimi M., Regelson W. The Biologic Role of Dehydroepiandrosterone (DHEA). 1990;Walter De Gruyter & Co, Berlin, Germany.
16. Barrett-Connor E., Khaw K.T. Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in postmenopausal women. N Engl J Med. 317:1987;711.
17. Barrett-Connor E., Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation. 91:1995;1757-1760.
18. Castelli W.P. Cardiovascular disease in women. Am J Obstet Gynecol. 158:1988;1553-1560.
19. Consensus Development Panel on Triglyceride N.I.H., High-Density Lipoprotein, Coronary Heart Disease Tryclyceride, high-density lipoprotein, and coronary heart disease. JAMA. 269:1993;505-510.
20. Nafziger A.N., Jenkins P.L., Bowlin S.J., Pearson T.A. Dehydroepiandrosterone, lipids, and apoproteins. Associations in a free-living population. (Abstract) Circulation. 82(Suppl III):1990;III-469.
21. Haffner S.M., Newcomb P.A., Marcus P.M., Klein B.E.K., Klein R. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol. 142:1995;925-934.
22. Barrett-Connor E., Goodman-Gruen D. The epidemiology of DHEAS and cardiovascular disease. In. Bellino FL, Daynes RA, Hornsby PJ, Lavrin DH, Nestler JE, Eds. Dehydroepiandrosterone (DHEA) and Aging Annals NY Acad Sci. 774:1995;259-270.
23. Newcomb P.A., Klein R., Klein B.E.K., Haffner S., Mares-Perlman J., Cruickshanks K.J., Marcus P.M. Association of dietary and lifestyle factors with sex hormones in postmenopausal women. Epidemiology. 6:1995;318-321.
24. McKinlay J.B., McKinlay S.M., Brambilla D.J. Health status and utilization behavior associated with menopause. Am J Epidemiol. 125:1987;110-121.
25. Longcope C., Herbert P.N., McKinlay S.M., Goldfield S.R. The relationship of total and free estrogens and sex hormone-binding globulin with lipoproteins in women. J Clin Endocrinol Metab. 71:1990;67-72.
26. Longcope C., Watson D., Williams K.I.H. The effects of synthetic estrogens on the metabolic clearance and production rates of estrone and estradiol. Steroids. 24:1974;15-30.
27. Longcope C., Hui S.L., Johnston C.C. Jr. Free estradiol, free testosterone and sex hormone binding globulin in peri-menopausal women. J Clin Endocrinol Metab. 64:1987;513-518.
28. Franz C., Watson D., Longcope C. Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis. Steroids. 34:1979;563-573.
29. Longcope C., Bourget C., Flood C. The production and aromatization of dehydroepiandrosterone in postmenopausal women. Maturitas. 4:1987;325-332.
30. Sady S.P., Thompson P.D., Cullinane E.M., Kantor M.A., Domagala E., Herbert P.N. Prolonged exercise augments plasma triglyceride clearance. JAMA. 256:1986;2552-2555.
31. Herbert P.N., Hyams J.S., Bernier D.N.et al. Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis J Clin Invest. 76:1985;403-412.
32. Khavari K.A., Farber P.D. A profile instrument for the quantification and assessment of alcohol consumption. J Stud Alcohol. 39:1978;1525-1539.
33. Liang K.-Y., Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika. 72:1986;13-22.
34. Kannell W.B., Hjortland M.C., McNamara P.M., Gordon T. Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med. 85:1976;447-452.
35. Razay G., Heaton K.W., Bolton C.H. Coronary heart disease risk factors in relation to the menopause. Q J Med. 85:1992;307-308. 889-896.
36. Longcope C., Franz D., Morello C., Baker R., Johnston C.C. Jr. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas. 8:1986;189-196.
37. Zumoff B., Rosenfeld R.S., Strain G.W., Levin J., Fulushima D.K. Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHS) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab. 51:1980;330-333.
38. Johannes C.B., Feldman H.A., Stellato R.K., McKinlay S.M. The effect of the menopausal transition and aging on DHEAS levels in women. (Abstract). Am J Epidemiol. 143:1996;S64.
39. Cohn J.S., McNamara J.R., Schaefer E.J. Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states. Clin Chem. 34:1988;2456-2459.
40. Rifai N., Merrill J.R., Holly R.G. Postprandial effect of a high fat meal on plasma lipid, lipoprotein cholesterol and apolipoprotein measurements. Ann Clin Biochem. 27:1990;489-493.
41. Wilson P.W.F. High-density lipoprotein, low-density lipoprotein and coronary artery disease. Am J Cardiol. 66:1990;7A-10A.
42. DHEA Info Page DHEA Ultra, World Wide Web, http://thayne.simlenet.com/dhea/ultra1.html , 11/10/97.
43. DHEA Connection, World Wide Web, http://www.tusconlink.com/dheaconn/dheares.htm , 11/10/97.
44. Labrie F., Belanger A., Simard J., Luu-The V., Labrie C. DHEA and peripheral androgen and estrogen formation. Intracrinology. In: Bellino FL, Daynes RA, Hornsby PJ, Lavrin DH, Nestler JE, Eds. Dehydroepiandrosterone (DHEA) and Aging Ann NY Acad Sci. 774:1995;16-28.
45. Schwartz A.G., Fairman D.K., Paschko L.L. The biological significant of dehydroepiandrosterone. Kalimi M.N., Regelson W. The Biologic Role of Dehydroepiandrosterone (DHEA). 1990;Walter De Gruyter & Co, Berlin, Germany.
46. Mortola J.F., Yen S.S.C. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 71:1990;696-704.
47. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 78:1994;1360-1367.
48. Khaw K.-T. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. J Endocrinol. 150:1996;S149-S153.